It has been suggested that oxygen-derived free radicals may contribute to the myocardial injury associated with ischemia and reperfusion (1) (2) (3) (4) (5) . Recently, using electron spin resonance (ESR) spectroscopy (6-15) and enhanced chemiluminescence (16), direct evidence of increased oxy gen-derived free radical production during reperfusion has been obtained. However, it is difficult to apply these methods to measure oxygen-derived free radicals generat ed in reoxygenated ischemic hearts without sophisticated techniques or special apparatuses. ESR requires freeze clamping of the tissue and spin trapping agents such as 5,5-dimethyl-l-pyrroline-N-oxide (DMPO) and a-phenyl N-tert-butyl nitrone (PBN) to prolong the lives of oxygen derived free radicals and produce long-lived products, respectively.
Chemiluminescence requires a special apparatus, such as a light-tight box in which a perfusion system of the isolated heart is included, to measure oxygen-derived free radical generation without delay.
In this study, we have developed a simple and reproducible method using chemiluminescence to meas ure oxygen-derived free radicals generated in oxygenated myocardium. Furthermore, we have examined the effect of recombinant human superoxide dismutase (r-h-SOD) and chemically inactivated r-h-SOD (Apo-SOD) on these radicals.
MATERIALS AND METHODS

Materials
Thirty-two male Wistar rats (Charles River Japan, 340-420 g) were used. Recombinant human copper-zinc superoxide dismutase (r-h-SOD) has a molecular weight of about 32,000 and contains two protein subunits, each of which bears an active site containing one copper ion and one zinc ion. Apo-SOD was obtained by chemical in activation of r-h-SOD as follows: r-h-SOD was incubated with a chelating agent, ethylene diamine tetraacetic acid (EDTA), to remove the copper and zinc at the active sites (17). R-h-SOD and Apo-SOD were provided by Nippon Kayaku Co., Ltd. (Tokyo) and dissolved in phosphate buffered saline (PBS, pH 7.4). The specific activities of r-h-SOD and Apo-SOD, determined according to the method of McCord and Fridovich (18), were 4530 and 50 U/mg protein, respectively. Lucigenin (N,N'-dimethyl 9,9'-biacridinium dinitrate, Sigma, St. Louis, MO, U.S.A.), hypoxanthine (Sigma) and xanthine oxidase (Boehringer, Mannheim, Germany) were also dissolved in PBS.
The partial pressure of oxygen (Po2) in PBS was meas ured with a blood gas analyzer (Model 288, Ciba-Corn ing, Corning, NY, U.S.A.).
Perfusion protocol
Animals were divided into three groups, the non-ische mia group (n=6), ischemia group (n=20) and reperfu sion group (n= 6). Under ether anesthesia, rat hearts were quickly removed after intravenous administration of 200 IU heparin and placed in ice-cold modified Tyrode's buffer, containing 128 mM NaC1, 4.7 mM KCI, 1.3 mM CaC12, 20.2 mM NaHCO3, 0.4 mM NaH2PO4, 1 MM MgC12 and 11 mM glucose. Immediately after cessation of contraction, the hearts were cannulated in the aorta and perfused at a constant pressure of 100 cmH2O by Langendorff's method. Perfusions were carried out with modified Tyrode's buffer saturated with a gas mixture (95% 02-5% C02) at 371C and pH 7.4. After 15 min of control perfusion, the hearts were subjected to global ischemia for 30 min by clamping the aortic perfusion line. St. Thomas' Hospital cardioplegic solution, which con tains 110 mM NaC1, 16 mM KCI, 1.2 mM CaC12, 10 MM NaHCO3 and 16 mM MgC12, was infused through a branch of the aortic perfusion line for 3 min immediately after the clamp. The hearts were immersed in the cardioplegic solution at 371C during the ischemic period. After 30 min of global ischemia, the hearts were reper fused with modified Tyrode's buffer for 20 min. The hearts were frozen in liquid nitrogen at various stages, that is, after 15 min of control perfusion (non-ischemia group), 30 min of global ischemia (ischemia group), or 20 min of reperfusion following 30-min global ischemia (reperfusion group), and stored at -801C for about 1 week until assayed. The influence of the storage period on the chemiluminescence intensity of oxygenated myocardi um was preliminarily examined. No difference was ob served between freshly prepared myocardium and that stored at 80 C for 1 week.
Oxygenation and chemiluminescence assay Stored frozen hearts were broken into fragments with a hammer, and then put in a teflon capsule containing a tungsten-carbide ball previously immersed in a liquid nitrogen bath and ground for 30 sec to a fine powder with a microdismembrator (B. Braun, Melsungen, Germany). The powder was transferred to a test tube and weighed ex actly. Immediately after adding 1 ml of PBS (pH 7.4 and Po2 of 183 -194 mmHg) containing lucigenin, the tube was vortexed for 10 sec to thaw and oxygenate the myo cardium. One milliliter of the mixed solution was injected into the flow cell of a chemiluminescence detector (CLD 100, Tohoku Electronic Industrial Co., Ltd., Sendai) 15 sec after vortexing.
As the volume of the flow cell was 0.5 ml, the remain ing 0.5 ml of solution filled the dead volume or over flowed. Chemiluminescence intensity was recorded on a desktop recorder (RC-250, Jasco, Tokyo) for 5 min. The area under the 5 min trace was measured with a digitizer (KD4300, Graphtec Co., Ltd., Tokyo) to quantify chemiluminescence intensity. The area under a trace ob tained from a mixed solution of hypoxanthine (10 pM), xanthine oxidase (10 mU/ml) and lucigenin (1 mg/ml) was defined as one chemiluminescence unit (CU) in this study (Fig. 1) . Fig. 1 . Actual trace of lucigenin-enhanced chemiluminescence of superoxide generated by hypoxanthine and xanthine oxidase. Lucigenin (1 mg/ml), hypoxanthine (10 uM) and xanthine oxidase (10 mU/ml) were mixed in 1 ml of PBS at 371C, and the chemi luminescence was recorded. The area under the recorded curve was measured and defined as one chemiluminescence unit (CU) in this study. Solid and outlined triangles indicate the injections of the mixed solution and water, respectively.
Statistics
All data are expressed as means±S.E.M. A paired t test was carried out to determine any differences between the mean values of each group. A one-way analysis of variance (ANOVA) was performed to test differences be tween the mean values of all groups. When a difference was observed, individual means were compared by Tukey's multiple comparison test. A probability of < 5 % was considered significant. 
RESULTS
Effects of the lucigenin and myocardium contents and the temperature of PBS on chemiluminescence intensity Lucigenin content: Four ischemic hearts were used. Frozen myocardium powder of 50 mg wet weight was mix ed with 1 ml of PBS (pH 7.4, Pot of 183 -194 mmHg and 371C) containing lucigenin at concentrations of 0, 0.016, 0.06, 0.25, 1 and 4 mg/ml. Little increase in chemi luminescence intensity was observed after injection of PBS containing only myocardium into the flow cell of the chemiluminescence detector (Fig. 2A) . However, a re markable increase in chemiluminescence intensity was observed after injection of PBS containing both myo cardium and lucigenin (Fig. 2B) . This intensity reached a maximal level immediately after the injection and de creased exponentially, but did not return to the baseline level within the 5 min recording period. Chemilumines cence intensity increased in relation to the concentration of lucigenin from 0.016 to 0.25 mg/ml, plateaued at 0.25 and 1 mg/ml and slightly decreased at 4 mg/ml (Fig. 3) .
Myocardium content: Four ischemic hearts were used. Frozen myocardium powder of 0, 25, 50 and 75 mg wet weight was mixed with 1 ml of PBS (pH 7.4, Pot 183 -194 mmHg and 371C) containing 1 mg of lucigenin. No increase in chemiluminescence intensity was observed after injection of PBS containing lucigenin but not myo cardium (Fig. 2C) . As shown in Fig. 4 , chemilumines cence intensity increased with increasing myocardium con tent.
Temperature of PBS: Four ischemic hearts were used. Frozen myocardium powder of 50 mg wet weight was mix ed with 1 ml of PBS (pH 7.4 and Pot of 183 -194 mmHg) containing 1 mg of lucigenin at temperatures of 25 IC, 37'C and 50'C. There were no significant differences in chemiluminescence intensity at temperatures of 251C, 371C and 501C (Table 1) . Values are the means±S.E.M. PBS at temperatures of 251C, 371C and 50'C was used. There were no statistically significant differences in chemiluminescence (ANOVA). The chemiluminescence unit (CU) is described in the text and Fig. 1 .
Fig. 5. Actual traces of chemiluminescence response to oxygenated non-ischemic (A), ischemic (B) and reperfused (C) myocardium.
Frozen and ground myocardium of 50 mg was mixed with I ml of PBS containing 1 mg of lucigenin, and the chemiluminescence was recorded. Solid and outlined triangles indicate the injections of the mixed solution and water, respectively. . Chemiluminescence intensities of oxygenated non-ischemic, ischemic and reperfused myocardium and the effects of Apo-SOD and r-h-SOD. Apo-SOD at 5 U/ml and r-h-SOD at 400 U/ml were dissolved in PBS containing lucigenin. Values are the means± S.E.M. of 6 stored hearts. The chemiluminescence unit (CU) is described in the text and Fig. 1 . *P<0.05, compared with each con trol using a paired t-test. ##P<0.01, compared with non-ischemia and reperfusion using Tukey's test. Chemiluminescence intensities of oxygenated non-ische mic, ischemic and reperfused myocardium and the effects of r-h-SOD and Apo-SOD Six hearts in each group of non-ischemia, ischemia and reperfusion were used. Frozen myocardium powder of 50 mg wet weight was mixed with 1 ml of PBS (pH 7.4, Pot of 183 194 mmHg and 371C) containing 1 mg of lucige nin. R-h-SOD at 400 U/ml or Apo-SOD at 5 U/ml was dissolved in PBS. Chemiluminescence was observed by oxygenation of non-ischemic, ischemic and reperfused myocardium (Fig. 5: A, B and C, respectively) . The chemi luminescence intensity obtained from oxygenation of ischemic myocardium (0.78 ± 0.06 CU) was significantly larger (P<0.01) than that of non-ischemic (0.31±0.04 CU) and reperfused (0.31 ±0.03 CU) myocardium (Fig.  6 ). There was no difference in the chemiluminescence in tensity obtained from non-ischemic and reperfused myo cardium. R-h-SOD significantly reduced the chemilumi nescence intensity induced by oxygenation of ischemic and non-ischemic myocardium (P<0.05). However, Apo-SOD did not reduce the chemiluminescence intensity induced by oxygenation of non-ischemic, ischemic or reperfused myocardium.
Dose-response study of r-h-SOD on chemiluminescence intensity
Six ischemic hearts were used. Frozen myocardium powder of 50 mg wet weight was mixed with 1 ml of PBS (pH 7.4, Pot of 183 -194 mmHg and 371C) containing 1 mg of lucigenin and 40, 400 and 4,000 U of r-h-SOD. R h-SOD reduced the chemiluminescence intensity dose-de pendently and significantly (Fig. 7) .
Reproducibility of this method Five assays using 1 ml of PBS (pH 7.4, 371C and Pot of 183 -194 mmHg) containing 1 mg of lucigenin and 50 mg wet weight of ischemic myocardium were performed. There were no significant differences among the assays (Table 2) . Table 2 .
Reproducibility of the present method
Values are the means±S.E.M. Five assays using 1 ml of PBS (pH 7.4, 371C and Pot 183 -194 mmHg) containing I mg of lucigenin and 50 mg wet weight of ischemic myocardium were performed. There were no statistically significant differences in chemiluminescence (ANOVA).
DISCUSSION
We have developed a simple method employing chemi luminescence to measure the oxygen-derived free radicals generated in the rat myocardium.
In this study, isolated rat hearts perfused by Langen dorff's method were frozen in liquid nitrogen and stored at 80'C for 1 week until assayed. Individual stored frozen hearts were ground to a fine powder. The powder was thawed and oxygenated in PBS containing lucigenin, and the chemiluminescence of the mixed solution was measured. The oxygen tension in intact myocardial tissue is reported to be 15 to 25 mmHg (19). Therefore, PBS in which the oxygen tension is maintained at 183-194 mmHg contains enough oxygen to oxygenate myocardial tissue.
In previous reports (6-16), the oxygen-derived free radicals that were generated in ischemia-reperfusion hearts in vitro or in vivo were measured by ESR or chemi luminescence. However, the radicals could not be meas ured by the present method because of their instability even at 801C (6). Our purpose in freezing the myo cardium was not to prolong the life of the generated oxy gen-derived free radicals, but to preserve the myocardial ability to generate these radicals. A number of mechanisms of oxygen-derived free radi cal generation in myocardium have been proposed (20). Xanthine oxidase, which is converted from xanthine de hydrogenase during ischemia, is considered to be a poten tial source of the superoxide anion radical (02) in rat myocardium (21, 22). Therefore, lucigenin was chosen as a chemiluminescence enhancer, which is known to be very sensitive to 02 compared with other activated oxygen species such as hydrogen peroxide and hydroxyl radical (23). One chemiluminescence unit was determined by measuring the area under a chemiluminescence curve ob tained from the hypoxanthine-xanthine oxidase reaction in our study.
To apply the present method to the measurement of oxygen-derived free radical generation with stored myo cardium, a few basic examinations were performed. Con sequently, it was shown that chemiluminescence intensity depends on the lucigenin and myocardium contents of a test solution, but is not influenced by the temperature of PBS ranging from 251C to 501C. Based on these results, the myocardium and lucigenin contents of test solutions were kept constant in subsequent experiments. It was also shown by inter-assay comparison that this method is reproducible.
Subsequently, stored non-ischemic, ischemic and reper fused myocardial tissues were oxygenated and their chemiluminescences were measured. A remarkable in crease in the chemiluminescence intensity was observed in oxygenated ischemic myocardium. There were no differ ences in the chemiluminescence intensities, which were smaller than that of ischemic myocardium, of non-ischem ic and 20-min reperfused myocardial tissues. These results indicated that a large increase in oxygen-derived free radi cal generation was elicited by oxygenation of ischemic myocardium and that the ability of myocardium to gener ate oxygen-derived free radicals was lost within 20 min after reperfusion. Similar results have been reported by others using ESR (6-15) or chemiluminescence (16).
Finally, the effect of recombinant human superoxide dismutase (r-h-SOD), a scavenger of 02, on the chemi luminescence intensity was examined. R-h-SOD reduced the chemiluminescence intensities in non-ischemic, ische mic and reperfused myocardium. Especially, a significant and dose-dependent inhibitory effect of r-h-SOD was ob served in ischemic myocardium. Therefore, 02 is likely to be the predominant radical in oxygenated stored rat myocardium. However, a fair amount of chemilumines cence was still observed despite the abundant application of r-h-SOD. Furtheremore, the standard chemilumines cence curve drawn from the hypoxanthine-xanthine oxi dase reaction reduced exponentially from the peak to the baseline level during a 5-min period of observation, but the chemiluminescence curve of the test solution contain ing myocardium did not recover to the baseline level with in the same period of observation. These results suggest the presence of non-specific luminescence produced by myocardial tissue and lucigenin which is not degraded by SOD (16, 24) . Macroscopically, oxygen-derived free radical genera tion measured by our method followed the same time course as others reported using intact hearts (6-16). Microscopically, however, there exist two points differen tiating our method from conventional methods. First, as stored frozen hearts are ground to a fine powder and oxy genated, the radical species generated and their sources in this study are probably different from those of intact myocardium. Secondly, using our method, the pharmaco logical effects of radical scavengers, such as SOD, man nitol and so on, could be examined by applying them to a solution containing myocardium powder; by conven tional methods, the pharmacological effects of the drugs could be examined by adding them to intact hearts. So, the dose that reduces chemiluminescence intensity in our method may not necessarily be equal to the dose that shows some efficacy in intact hearts. Therefore, in the ap plication of this method to pathophysiological or pharma cological investigations, other experiments using intact or gans may also be needed. Although such methodological limits exist in this method, this method is useful for the screening of free radical scavengers because of its simplici ty and reproducibility.
In conclusion, a simple and reproducible chemilumines cence method for measuring oxygen-derived free radicals generated in oxygenated myocardium has been deve loped. Oxygen-derived free radicals are generated more in oxygenated ischemic myocardium than in oxygenated non-ischemic or reperfused myocardium. R-h-SOD sig nificantly and dose-dependently reduced the elevation of oxygen-derived free radical content after oxygenation.
